文献速递临床试验与 GCP流行病学与生物统计

维生素D、ω-3脂肪酸或力量训练对老年人临床结局的影响:DO-HEALTH随机临床试验

Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
PubMed 文献 · JAMA · 2020-01-01

DO-HEALTH试验纳入2157名70岁以上无重大疾病的老年人,采用2×2×2析因设计随机接受维生素D3、ω-3脂肪酸、力量训练或安慰剂干预3年。结果显示,这些干预单独或联合均未对收缩压和舒张压、短物理性能电池、蒙特利尔认知评估、非椎体骨折和感染发生率等6个主要结局产生统计学显著改善。

要点

  • 维生素D3、ω-3脂肪酸或力量训练单独或联合均未显著改善6个主要临床结局。
  • 在无重大合并症的70岁以上老年人中,不支持下述干预用于改善这些临床结局。

核心结论

  • 在70岁以上无重大合并症的老年人中,维生素D3、ω-3脂肪酸或力量训练干预未显著改善收缩压、舒张压、非椎体骨折、身体性能、感染率或认知功能。

研究设计与样本

  • 双盲、安慰剂对照的2×2×2析因随机临床试验,纳入2157名70岁及以上、过去5年无重大健康事件且行动能力和认知状态良好的成年人。
  • 参与者随机分配至8组,接受3年干预:维生素D3 2000 IU/d、ω-3脂肪酸1 g/d、力量训练运动项目或其组合及安慰剂。
  • 主要结局为3年内收缩压和舒张压变化、短物理性能电池(SPPB)、蒙特利尔认知评估(MoCA)以及非椎体骨折和感染的发生率。

主要发现

  • SPPB、MoCA和非椎体骨折发生率未见干预效果。
  • 共报告25例死亡,各组数量相似。

临床怎么用

  • 对于无重大合并症的70岁以上老年人,不应基于改善血压、身体性能、认知功能、骨折或感染风险的目的常规推荐维生素D3、ω-3脂肪酸或力量训练。

局限性

  • 研究纳入的是行动能力良好且认知状态正常的老年人,结果可能不适用于其他人群。
  • 随访时间限于3年,长期效果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear. OBJECTIVE: To test whether vitamin D, omega-3s, and a strength-training exercise program, alone or in combination, improved 6 health outcomes among older adults. DESIGN, SETTING, AND PARTICIPANTS: Double-blind, placebo-controlled, 2 × 2 × 2 factorial randomized clinical trial among 2157 adults aged 70 years or older who had no major health events in the 5 years prior to enrollment and had sufficient mobility and good cognitive status. Patients were recruited between December 2012 and November 2014, and final follow-up was in November 2017. INTERVENTIONS: Participants were randomized to 3 years of intervention in 1 of the following 8 groups: 2000 IU/d of vitamin D3, 1 g/d of omega-3s, and a strength-training exercise program (n = 264); vitamin D3 and omega-3s (n = 265); vitamin D3 and exercise (n = 275); vitamin D3 alone (n = 272); omega-3s and exercise (n = 275); omega-3s alone (n = 269); exercise alone (n = 267); or placebo (n = 270). MAIN OUTCOMES AND MEASURES: The 6 primary outcomes were change in systolic and diastolic blood pressure (BP), Short Physical Performance Battery (SPPB), Montreal Cognitive Assessment (MoCA), and incidence rates (IRs) of nonvertebral fractures and infections over 3 years. Based on multiple comparisons of 6 primary end points, 99% confidence intervals are presented and P < .01 was required for statistical significance. RESULTS: Among 2157 randomized participants (mean age, 74.9 years; 61.7% women), 1900 (88%) completed the study. Median follow-up was 2.99 years. Overall, there were no statistically significant benefits of any intervention individually or in combination for the 6 end points at 3 years. For instance, the differences in mean change in systolic BP with vitamin D vs no vitamin D and with omega-3s vs no omega-3s were both -0.8 (99% CI, -2.1 to 0.5) mm Hg, with P < .13 and P < .11, respectively; the difference in mean change in diastolic BP with omega-3s vs no omega-3s was -0.5 (99% CI, -1.2 to 0.2) mm Hg; P = .06); and the difference in mean change in IR of infections with omega-3s vs no omega-3s was -0.13 (99% CI, -0.23 to -0.03), with an IR ratio of 0.89 (99% CI, 0.78-1.01; P = .02). No effects were found on the outcomes of SPPB, MoCA, and incidence of nonvertebral fractures). A total of 25 deaths were reported, with similar numbers in all treatment groups. CONCLUSIONS AND RELEVANCE: Among adults without major comorbidities aged 70 years or older, treatment with vitamin D3, omega-3s, or a strength-training exercise program did not result in statistically significant differences in improvement in systolic or diastolic blood pressure, nonvertebral fractures, physical performance, infection rates, or cognitive function. These findings do not support the effectiveness of these 3 interventions for these clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01745263.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA. 2020. PMID: 33170239. doi:10.1001/jama.2020.16909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。